Market closed · Next open: Monday 9:30 AM ET
Last update: Nov 20, 2026, 6:14 PM ET
McKesson Corporation
$1,069.43▲ 0.68% today
Market Closed

Why McKesson Corporation (MCK) stock moved

No significant move on Nov 20, 2026 (+0.7%, close-to-close). Latest notable session: Nov 4, 2026.

Latest session▲ 7.0% · Nov 4, 2026 close

Why McKesson Corporation (MCK) rose 7.0% on November 4, 2026

McKesson Corporation (MCK) rose 7.0% on November 4, 2026, closing at $1,069.44 versus $999.62 the prior session (close-to-close, from daily closes). Ahead of second-quarter fiscal 2027 earnings results scheduled for release after market close today, November 4, according to investing.com and finance.yahoo.com. Investors are positioned for the report citing analyst expectations of $10.69 EPS on $110.11B revenue, with particular focus on GLP-1 medication distribution volumes—which surged 24% year-over-year to $15B last quarter—and recent strategic moves including its $1.4B stake in Option Care Health. Source: Yahoo Finance.

Updated
Prior close
$999.62
Nov 4, 2026 close
$1,069.44
Change (close-to-close)
+$69.82
+6.98%
As first detected · Nov 4, 2026, 12:42 PM ET

McKesson rallied 6.85% to $1,068.05 ahead of second-quarter fiscal 2027 earnings results scheduled for release after market close today, November 4, according to investing.com and finance.yahoo.com. Investors are positioned for the report citing analyst expectations of $10.69 EPS on $110.11B revenue, with particular focus on GLP-1 medication distribution volumes—which surged 24% year-over-year to $15B last quarter—and recent strategic moves including its $1.4B stake in Option Care Health.

What to watch next: McKesson's Q2 fiscal 2027 earnings release and 4:30 PM ET conference call today; key metrics to monitor are GLP-1 distribution volume trends and updated full-year guidance.

Source: Yahoo Finance · percentages in this note are as captured at detection; the confirmed close-to-close move is shown above.

Earlier sessions that moved MCK

  1. +5.3%McKesson Corporation extended its pharmaceutical distribution agreement with CVS Health, a major contract renewal announced via Business Wire.

McKesson Corporation (MCK) shares rose 0.7% to $1,069.43 as of November 22, 2026, a slight gain from the prior close of $1,062.16. BestStocks flagged the session as a major change for MCK. The move is tied to company news. Below, we break down what changed for MCK, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

Company News

Bessemer Group Inc. reduced its MCK stake by 10.6%, selling 927 shares to retain 7,791 shares. Insider selling signals potential weakness; large institutional exits can pressure stock and suggest diminished conviction.

This summary describes the catalyst and move as first detected on Nov 20, 2026, 10:12 AM EST; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
NewsWeak confidence
Rel. volume
1.0×
Normal
Vs peers
—
No comparable peers
Market cap
$123.5B
New York Stock Exchange
Analyst target
$999
-6.6% vs price
Price chart
Oct 22 – Nov 20
VNNNNNFE$959$1033$1107Oct 22Oct 29Nov 6Nov 13Nov 20
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for McKesson Corporation investors

For McKesson Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 0.7% session move; Positive price momentum. Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $998.57, implying -6.6% downside from $1,069.43. BestStocks rates the overall signal quality weak (37/100). With earnings roughly 73 days out, the next report is the most likely near-term test of the move.

MCK price reaction

MCK last traded at $1,069.43, up $7.27 (+0.68%) from the previous close of $1,062.16. The session traded on 1.0× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $960.56 and $1,105.04, and it currently sits about 75% of the way up that band.

Bullish and bearish analyst opinions on McKesson Corporation (MCK)

The consensus analyst price target on McKesson Corporation (MCK) is $998.57, 6.6% below the recent $1,069.43. Over the past 90 days analysts logged 0 upgrades, 10 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MCK line up.

The bullish case

  • The Street's most bullish target is $1,200.00 (+12.2%).
  • Positive 0.7% session move.
  • Positive price momentum.
  • McKesson Corporation (MCK) moved +5.65% from $796.35 to $841.31 on 2026-07-16, reaching a new 30-day high on modestly elevated volume (1.7x the 5-day average).

The bearish case

  • The consensus analyst price target of $998.57 sits 6.6% below the recent $1,069.43, so the average target sees limited room to run.
  • The most bearish analyst target is $845.00 (-21.0%).
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Nov 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $999-6.6%
= 10 maintains
JP Morgan maintained Overweight · 2026-11-10
SEC filings watch
8-K2026-11-04
Material event — review for impact
high
10-Q2026-11-04
Quarterly financial results
medium
8-K2026-10-06
Material event — review for impact
high
8-K2026-08-28
Material event — review for impact
high
Peer context
MCK+0.7%

Previous notable changes for MCK

News2026-11-17-1.2%
Article compares McKesson's financial metrics and investment characteristics against INVO Fertility across dividends, profitability, and valuation.
News2026-11-15
Allworth Financial LP increased its MCK stake by 15.7%, acquiring 861 additional shares to reach 6,359 total shares.
News2026-11-13+2.4%
McKesson faces slower FY2028 revenue growth despite strong specialty drug demand, limiting upside potential.
News2026-11-11-0.3%
MCK shares reached new highs driven by pharmaceutical sales growth and GLP-1 demand.

In-depth MCK event analyses

Permanent, dated analyses of MCK's most significant sessions.
Upcoming catalysts & outlook
Next earnings
2027-02-03 (est.)
in 73 days
Thesis shift
Neutral / Mixed
bullish signal
Risk level
Low
from change events

Frequently asked questions about MCK

Why did McKesson Corporation (MCK) stock move?

McKesson Corporation (MCK) rose 7.0% on November 4, 2026, closing at $1,069.44 versus $999.62 the prior session (close-to-close, from daily closes). Ahead of second-quarter fiscal 2027 earnings results scheduled for release after market close today, November 4, according to investing.com and finance.yahoo.com. Investors are positioned for the report citing analyst expectations of $10.69 EPS on $110.11B revenue, with particular focus on GLP-1 medication distribution volumes—which surged 24% year-over-year to $15B last quarter—and recent strategic moves including its $1.4B stake in Option Care Health. Source: Yahoo Finance.

How much did MCK stock rise?

MCK gained 0.68% ($7.27) versus the prior close of $1,062.16, last trading at $1,069.43 on 1.0× average volume.

When is McKesson Corporation's next earnings date?

MCK's next earnings report is estimated for 2027-02-03 — about 73 days away.

What is the analyst price target for MCK?

The consensus analyst price target for MCK is $998.57, about 6.6% below the current $1,069.43. Over the past 90 days, analysts recorded 0 upgrades, 10 maintains, and 0 downgrades.

How BestStocks tracks MCK

This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for MCK, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 22, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.